Cancer and aging: a model for the cancer promoting effects of the aging stroma

被引:228
作者
Krtolica, A [1 ]
Campisi, J [1 ]
机构
[1] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA
关键词
antagonistic pleiotropy; cellular senescence; oncogenic mutations; tissue microenvironment; tumor suppression;
D O I
10.1016/S1357-2725(02)00053-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The incidence of cancer rises exponentially with age in humans and many other mammalian species. Malignant tumors are caused by an accumulation of oncogenic mutations. In addition, malignant tumorigenesis requires a permissive tissue environment in which mutant cells can survive, proliferate, and express their neoplastic phenotype. We propose that the age-related increase in cancer results from a synergy between the accumulation of mutations and age-related, pro-oncogenic changes in the tissue milieu. Most age-related cancers derive from the epithelial cells of renewable tissues. An important element of epithelia] tissues is the stroma, the sub-epithelial layer composed of extracellular matrix and several Cell types. The stroma is maintained, remodeled and repaired by resident fibroblasts, supports and instructs the epithelium, and is essential for epithelial function. One change that occurs in tissues during aging is the accumulation of epithelial cells and fibroblasts that have undergone cellular senescence. Cellular senescence irreversibly arrests proliferation in response to damage or stimuli that put cells at risk for neoplastic transformation. Senescent cells secrete factors that can disrupt tissue architecture and/or stimulate nearby cells to proliferate. We therefore speculate that their presence may create a pro-oncogenic tissue environment that synergizes with oncogenic mutations to drive the rise in cancer incidence with age. Recent evidence lends support to this idea, and suggests that senescent stromal fibroblasts may be particularly adept at creating a tissue environment that can promote the development of age-related epithelial cancers. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1401 / 1414
页数:14
相关论文
共 130 条
[81]  
2-B
[82]   DIFFERENTIAL EXPRESSION OF METALLOPROTEINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE GENES IN AGED HUMAN FIBROBLASTS [J].
MILLIS, AJT ;
HOYLE, M ;
MCCUE, HM ;
MARTINI, H .
EXPERIMENTAL CELL RESEARCH, 1992, 201 (02) :373-379
[83]  
Mishima K, 1999, INVEST OPHTH VIS SCI, V40, P1590
[84]   The telomerase reverse transcriptase: components and regulation [J].
Nugent, CI ;
Lundblad, V .
GENES & DEVELOPMENT, 1998, 12 (08) :1073-1085
[85]  
Ogryzko VV, 1996, MOL CELL BIOL, V16, P5210
[86]  
OHEBRANIOUS N, 1998, ONCOGENE, V17, P3385
[87]  
Olumi AF, 1999, CANCER RES, V59, P5002
[88]   Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas [J].
Paradis, V ;
Youssef, N ;
Dargère, D ;
Bâ, N ;
Bonvoust, F ;
Deschatrette, J ;
Bedossa, P .
HUMAN PATHOLOGY, 2001, 32 (03) :327-332
[89]   The influence of the microenvironment on the malignant phenotype [J].
Park, CC ;
Bissell, MJ ;
Barcellos-Hoff, MH .
MOLECULAR MEDICINE TODAY, 2000, 6 (08) :324-329
[90]  
Pendergrass WR, 1999, J CELL PHYSIOL, V180, P123, DOI 10.1002/(SICI)1097-4652(199907)180:1<123::AID-JCP14>3.0.CO